Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

The global Antibiotic Resistance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance.

Report Scope

The Antibiotic Resistance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotic Resistance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibiotic Resistance manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibiotic Resistance Market Report

Report Metric	Details
Report Name	Antibiotic Resistance Market
CAGR	5%
Segment by Type	By Disease By Pathogen
Segment by Application	Oxazolidinones Lipoglycopeptides Tetracyclines Cephalosporins Combination therapies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotic Resistance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotic Resistance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibiotic Resistance Market report?

Ans: The main players in the Antibiotic Resistance Market are Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health

What are the Application segmentation covered in the Antibiotic Resistance Market report?

Ans: The Applications covered in the Antibiotic Resistance Market report are Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Other

What are the Type segmentation covered in the Antibiotic Resistance Market report?

Ans: The Types covered in the Antibiotic Resistance Market report are By Disease, By Pathogen

1 Antibiotic Resistance Market Overview

1.1 Product Overview and Scope of Antibiotic Resistance

1.2 Antibiotic Resistance Segment By Disease

1.2.1 Global Antibiotic Resistance Market Value Comparison By Disease (2024-2030)

1.2.2 By Disease

1.2.3 By Pathogen

1.3 Antibiotic Resistance Segment by Application

1.3.1 Global Antibiotic Resistance Market Value by Application: (2024-2030)

1.3.2 Oxazolidinones

1.3.3 Lipoglycopeptides

1.3.4 Tetracyclines

1.3.5 Cephalosporins

1.3.6 Combination therapies

1.3.7 Other

1.4 Global Antibiotic Resistance Market Size Estimates and Forecasts

1.4.1 Global Antibiotic Resistance Revenue 2019-2030

1.4.2 Global Antibiotic Resistance Sales 2019-2030

1.4.3 Global Antibiotic Resistance Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antibiotic Resistance Market Competition by Manufacturers

2.1 Global Antibiotic Resistance Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antibiotic Resistance Average Price by Manufacturers (2019-2024)

2.4 Global Antibiotic Resistance Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antibiotic Resistance, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antibiotic Resistance, Product Type & Application

2.7 Antibiotic Resistance Market Competitive Situation and Trends

2.7.1 Antibiotic Resistance Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Antibiotic Resistance Players Market Share by Revenue

2.7.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibiotic Resistance Retrospective Market Scenario by Region

3.1 Global Antibiotic Resistance Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antibiotic Resistance Global Antibiotic Resistance Sales by Region: 2019-2030

3.2.1 Global Antibiotic Resistance Sales by Region: 2019-2024

3.2.2 Global Antibiotic Resistance Sales by Region: 2025-2030

3.3 Global Antibiotic Resistance Global Antibiotic Resistance Revenue by Region: 2019-2030

3.3.1 Global Antibiotic Resistance Revenue by Region: 2019-2024

3.3.2 Global Antibiotic Resistance Revenue by Region: 2025-2030

3.4 North America Antibiotic Resistance Market Facts & Figures by Country

3.4.1 North America Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antibiotic Resistance Sales by Country (2019-2030)

3.4.3 North America Antibiotic Resistance Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antibiotic Resistance Market Facts & Figures by Country

3.5.1 Europe Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antibiotic Resistance Sales by Country (2019-2030)

3.5.3 Europe Antibiotic Resistance Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antibiotic Resistance Market Facts & Figures by Country

3.6.1 Asia Pacific Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antibiotic Resistance Sales by Country (2019-2030)

3.6.3 Asia Pacific Antibiotic Resistance Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antibiotic Resistance Market Facts & Figures by Country

3.7.1 Latin America Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antibiotic Resistance Sales by Country (2019-2030)

3.7.3 Latin America Antibiotic Resistance Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Country

3.8.1 Middle East and Africa Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antibiotic Resistance Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antibiotic Resistance Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Antibiotic Resistance Sales by Type (2019-2030)

4.1.1 Global Antibiotic Resistance Sales by Type (2019-2024)

4.1.2 Global Antibiotic Resistance Sales by Type (2025-2030)

4.1.3 Global Antibiotic Resistance Sales Market Share by Type (2019-2030)

4.2 Global Antibiotic Resistance Revenue by Type (2019-2030)

4.2.1 Global Antibiotic Resistance Revenue by Type (2019-2024)

4.2.2 Global Antibiotic Resistance Revenue by Type (2025-2030)

4.2.3 Global Antibiotic Resistance Revenue Market Share by Type (2019-2030)

4.3 Global Antibiotic Resistance Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antibiotic Resistance Sales by Application (2019-2030)

5.1.1 Global Antibiotic Resistance Sales by Application (2019-2024)

5.1.2 Global Antibiotic Resistance Sales by Application (2025-2030)

5.1.3 Global Antibiotic Resistance Sales Market Share by Application (2019-2030)

5.2 Global Antibiotic Resistance Revenue by Application (2019-2030)

5.2.1 Global Antibiotic Resistance Revenue by Application (2019-2024)

5.2.2 Global Antibiotic Resistance Revenue by Application (2025-2030)

5.2.3 Global Antibiotic Resistance Revenue Market Share by Application (2019-2030)

5.3 Global Antibiotic Resistance Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Allergan

6.1.1 Allergan Corporation Information

6.1.2 Allergan Description and Business Overview

6.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Allergan Antibiotic Resistance Product Portfolio

6.1.5 Allergan Recent Developments/Updates

6.2 AmpliPhi Biosciences

6.2.1 AmpliPhi Biosciences Corporation Information

6.2.2 AmpliPhi Biosciences Description and Business Overview

6.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Portfolio

6.2.5 AmpliPhi Biosciences Recent Developments/Updates

6.3 BioVersys GmbH

6.3.1 BioVersys GmbH Corporation Information

6.3.2 BioVersys GmbH Description and Business Overview

6.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.3.4 BioVersys GmbH Antibiotic Resistance Product Portfolio

6.3.5 BioVersys GmbH Recent Developments/Updates

6.4 Macrolide Pharmaceuticals

6.4.1 Macrolide Pharmaceuticals Corporation Information

6.4.2 Macrolide Pharmaceuticals Description and Business Overview

6.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Portfolio

6.4.5 Macrolide Pharmaceuticals Recent Developments/Updates

6.5 Melinta Therapeutics

6.5.1 Melinta Therapeutics Corporation Information

6.5.2 Melinta Therapeutics Description and Business Overview

6.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Melinta Therapeutics Antibiotic Resistance Product Portfolio

6.5.5 Melinta Therapeutics Recent Developments/Updates

6.6 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Merck Antibiotic Resistance Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Nabriva Therapeutics

6.6.1 Nabriva Therapeutics Corporation Information

6.6.2 Nabriva Therapeutics Description and Business Overview

6.6.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Nabriva Therapeutics Antibiotic Resistance Product Portfolio

6.7.5 Nabriva Therapeutics Recent Developments/Updates

6.8 Nemesis Bioscience

6.8.1 Nemesis Bioscience Corporation Information

6.8.2 Nemesis Bioscience Description and Business Overview

6.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Nemesis Bioscience Antibiotic Resistance Product Portfolio

6.8.5 Nemesis Bioscience Recent Developments/Updates

6.9 Phage Technologies S.A

6.9.1 Phage Technologies S.A Corporation Information

6.9.2 Phage Technologies S.A Description and Business Overview

6.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Phage Technologies S.A Antibiotic Resistance Product Portfolio

6.9.5 Phage Technologies S.A Recent Developments/Updates

6.10 Tetraphase Pharmaceuticals

6.10.1 Tetraphase Pharmaceuticals Corporation Information

6.10.2 Tetraphase Pharmaceuticals Description and Business Overview

6.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Portfolio

6.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates

6.11 The Medicines Company

6.11.1 The Medicines Company Corporation Information

6.11.2 The Medicines Company Antibiotic Resistance Description and Business Overview

6.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.11.4 The Medicines Company Antibiotic Resistance Product Portfolio

6.11.5 The Medicines Company Recent Developments/Updates

6.12 TPfizer

6.12.1 TPfizer Corporation Information

6.12.2 TPfizer Antibiotic Resistance Description and Business Overview

6.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.12.4 TPfizer Antibiotic Resistance Product Portfolio

6.12.5 TPfizer Recent Developments/Updates

6.13 Westway Health

6.13.1 Westway Health Corporation Information

6.13.2 Westway Health Antibiotic Resistance Description and Business Overview

6.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Westway Health Antibiotic Resistance Product Portfolio

6.13.5 Westway Health Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antibiotic Resistance Industry Chain Analysis

7.2 Antibiotic Resistance Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antibiotic Resistance Production Mode & Process

7.4 Antibiotic Resistance Sales and Marketing

7.4.1 Antibiotic Resistance Sales Channels

7.4.2 Antibiotic Resistance Distributors

7.5 Antibiotic Resistance Customers

8 Antibiotic Resistance Market Dynamics

8.1 Antibiotic Resistance Industry Trends

8.2 Antibiotic Resistance Market Drivers

8.3 Antibiotic Resistance Market Challenges

8.4 Antibiotic Resistance Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Allergan plc

AmpliPhi Biosciences

BioVersys GmbH

Macrolide Pharmaceuticals

Phage Technologies S.A

Tetraphase Pharmaceuticals

The Medicines Company

TPfizer

Westway Health

List of Tables

Table 1. Global Antibiotic Resistance Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antibiotic Resistance Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Antibiotic Resistance Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antibiotic Resistance Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antibiotic Resistance Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antibiotic Resistance Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antibiotic Resistance Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antibiotic Resistance Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antibiotic Resistance, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antibiotic Resistance, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antibiotic Resistance, Product Type & Application

Table 12. Global Key Manufacturers of Antibiotic Resistance, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antibiotic Resistance Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antibiotic Resistance Sales by Region (2019-2024) & (K Units)

Table 18. Global Antibiotic Resistance Sales Market Share by Region (2019-2024)

Table 19. Global Antibiotic Resistance Sales by Region (2025-2030) & (K Units)

Table 20. Global Antibiotic Resistance Sales Market Share by Region (2025-2030)

Table 21. Global Antibiotic Resistance Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antibiotic Resistance Revenue Market Share by Region (2019-2024)

Table 23. Global Antibiotic Resistance Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antibiotic Resistance Revenue Market Share by Region (2025-2030)

Table 25. North America Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 27. North America Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 28. North America Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antibiotic Resistance Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antibiotic Resistance Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antibiotic Resistance Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antibiotic Resistance Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antibiotic Resistance Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antibiotic Resistance Sales (K Units) by Type (2019-2024)

Table 51. Global Antibiotic Resistance Sales (K Units) by Type (2025-2030)

Table 52. Global Antibiotic Resistance Sales Market Share by Type (2019-2024)

Table 53. Global Antibiotic Resistance Sales Market Share by Type (2025-2030)

Table 54. Global Antibiotic Resistance Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antibiotic Resistance Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antibiotic Resistance Revenue Market Share by Type (2019-2024)

Table 57. Global Antibiotic Resistance Revenue Market Share by Type (2025-2030)

Table 58. Global Antibiotic Resistance Price (USD/Unit) by Type (2019-2024)

Table 59. Global Antibiotic Resistance Price (USD/Unit) by Type (2025-2030)

Table 60. Global Antibiotic Resistance Sales (K Units) by Application (2019-2024)

Table 61. Global Antibiotic Resistance Sales (K Units) by Application (2025-2030)

Table 62. Global Antibiotic Resistance Sales Market Share by Application (2019-2024)

Table 63. Global Antibiotic Resistance Sales Market Share by Application (2025-2030)

Table 64. Global Antibiotic Resistance Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antibiotic Resistance Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antibiotic Resistance Revenue Market Share by Application (2019-2024)

Table 67. Global Antibiotic Resistance Revenue Market Share by Application (2025-2030)

Table 68. Global Antibiotic Resistance Price (USD/Unit) by Application (2019-2024)

Table 69. Global Antibiotic Resistance Price (USD/Unit) by Application (2025-2030)

Table 70. Allergan Corporation Information

Table 71. Allergan Description and Business Overview

Table 72. Allergan Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Allergan Antibiotic Resistance Product

Table 74. Allergan Recent Developments/Updates

Table 75. AmpliPhi Biosciences Corporation Information

Table 76. AmpliPhi Biosciences Description and Business Overview

Table 77. AmpliPhi Biosciences Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. AmpliPhi Biosciences Antibiotic Resistance Product

Table 79. AmpliPhi Biosciences Recent Developments/Updates

Table 80. BioVersys GmbH Corporation Information

Table 81. BioVersys GmbH Description and Business Overview

Table 82. BioVersys GmbH Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. BioVersys GmbH Antibiotic Resistance Product

Table 84. BioVersys GmbH Recent Developments/Updates

Table 85. Macrolide Pharmaceuticals Corporation Information

Table 86. Macrolide Pharmaceuticals Description and Business Overview

Table 87. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Macrolide Pharmaceuticals Antibiotic Resistance Product

Table 89. Macrolide Pharmaceuticals Recent Developments/Updates

Table 90. Melinta Therapeutics Corporation Information

Table 91. Melinta Therapeutics Description and Business Overview

Table 92. Melinta Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Melinta Therapeutics Antibiotic Resistance Product

Table 94. Melinta Therapeutics Recent Developments/Updates

Table 95. Merck Corporation Information

Table 96. Merck Description and Business Overview

Table 97. Merck Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Merck Antibiotic Resistance Product

Table 99. Merck Recent Developments/Updates

Table 100. Nabriva Therapeutics Corporation Information

Table 101. Nabriva Therapeutics Description and Business Overview

Table 102. Nabriva Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Nabriva Therapeutics Antibiotic Resistance Product

Table 104. Nabriva Therapeutics Recent Developments/Updates

Table 105. Nemesis Bioscience Corporation Information

Table 106. Nemesis Bioscience Description and Business Overview

Table 107. Nemesis Bioscience Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Nemesis Bioscience Antibiotic Resistance Product

Table 109. Nemesis Bioscience Recent Developments/Updates

Table 110. Phage Technologies S.A Corporation Information

Table 111. Phage Technologies S.A Description and Business Overview

Table 112. Phage Technologies S.A Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Phage Technologies S.A Antibiotic Resistance Product

Table 114. Phage Technologies S.A Recent Developments/Updates

Table 115. Tetraphase Pharmaceuticals Corporation Information

Table 116. Tetraphase Pharmaceuticals Description and Business Overview

Table 117. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Tetraphase Pharmaceuticals Antibiotic Resistance Product

Table 119. Tetraphase Pharmaceuticals Recent Developments/Updates

Table 120. The Medicines Company Corporation Information

Table 121. The Medicines Company Description and Business Overview

Table 122. The Medicines Company Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. The Medicines Company Antibiotic Resistance Product

Table 124. The Medicines Company Recent Developments/Updates

Table 125. TPfizer Corporation Information

Table 126. TPfizer Description and Business Overview

Table 127. TPfizer Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. TPfizer Antibiotic Resistance Product

Table 129. TPfizer Recent Developments/Updates

Table 130. Westway Health Corporation Information

Table 131. Westway Health Description and Business Overview

Table 132. Westway Health Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Westway Health Antibiotic Resistance Product

Table 134. Westway Health Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Antibiotic Resistance Distributors List

Table 138. Antibiotic Resistance Customers List

Table 139. Antibiotic Resistance Market Trends

Table 140. Antibiotic Resistance Market Drivers

Table 141. Antibiotic Resistance Market Challenges

Table 142. Antibiotic Resistance Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Antibiotic Resistance

Figure 2. Global Antibiotic Resistance Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antibiotic Resistance Market Share by Type in 2023 & 2030

Figure 4. Product Picture

Figure 5. Product Picture

Figure 6. Global Antibiotic Resistance Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Antibiotic Resistance Market Share by Application in 2023 & 2030

Figure 8. Oxazolidinones

Figure 9. Lipoglycopeptides

Figure 10. Tetracyclines

Figure 11. Cephalosporins

Figure 12. Combination therapies

Figure 13. Other

Figure 14. Global Antibiotic Resistance Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antibiotic Resistance Market Size (2019-2030) & (US$ Million)

Figure 16. Global Antibiotic Resistance Sales (2019-2030) & (K Units)

Figure 17. Global Antibiotic Resistance Average Price (USD/Unit) & (2019-2030)

Figure 18. Antibiotic Resistance Report Years Considered

Figure 19. Antibiotic Resistance Sales Share by Manufacturers in 2023

Figure 20. Global Antibiotic Resistance Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Antibiotic Resistance Players: Market Share by Revenue in 2023

Figure 22. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Antibiotic Resistance Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Antibiotic Resistance Sales Market Share by Country (2019-2030)

Figure 25. North America Antibiotic Resistance Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Antibiotic Resistance Sales Market Share by Country (2019-2030)

Figure 29. Europe Antibiotic Resistance Revenue Market Share by Country (2019-2030)

Figure 30. Germany Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Antibiotic Resistance Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Antibiotic Resistance Revenue Market Share by Region (2019-2030)

Figure 37. China Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Antibiotic Resistance Sales Market Share by Country (2019-2030)

Figure 48. Latin America Antibiotic Resistance Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Antibiotic Resistance Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Antibiotic Resistance Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. U.A.E Antibiotic Resistance Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Antibiotic Resistance by Type (2019-2030)

Figure 58. Global Revenue Market Share of Antibiotic Resistance by Type (2019-2030)

Figure 59. Global Antibiotic Resistance Price (USD/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Antibiotic Resistance by Application (2019-2030)

Figure 61. Global Revenue Market Share of Antibiotic Resistance by Application (2019-2030)

Figure 62. Global Antibiotic Resistance Price (USD/Unit) by Application (2019-2030)

Figure 63. Antibiotic Resistance Value Chain

Figure 64. Antibiotic Resistance Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Inhaled Nasal Influenza Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24O9093

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Needle-Free Influenza Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6Z9583

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Chronic Cough Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21Y10065

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

Global Antiviral Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2L14563

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions